Papers
2
Total Citations
34
H-Index
2
About
Zaibo Li is a leading pathologist whose research centers on advancing cytopathology through digital innovation, particularly in telecytology and rapid onsite evaluation (ROSE). His major contributions lie in systematically evaluating and comparing digital platforms for remote cytological assessment, addressing critical barriers to telemedicine in pathology. In a landmark 2018 study, Li comprehensively compared the VisionTek digital microscope with the Hamamatsu NanoZoomer for fine-needle aspiration-ROSE, demonstrating that robotic digital microscopy could achieve diagnostic accuracy comparable to traditional methods—a finding with 20 citations that has shaped subsequent telecytology protocols. His 2020 review, cited 14 times, synthesized evidence across multiple telecytology platforms, providing an essential framework for implementing ROSE in remote settings. This work has directly improved diagnostic quality and specimen triage in small biopsies, particularly for underserved populations. Li’s research bridges the gap between technological capability and clinical practicality, establishing evidence-based standards that enable pathologists to deliver real-time, high-quality cytopathology services regardless of geographic constraints—a contribution of growing importance in an era of expanding digital healthcare.
Research Focus
Key Achievements
Top Papers
- 1
- 2